Dynamic Technology Lab Private LTD Amgen Inc Transaction History

Dynamic Technology Lab Private LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $420,499 - $534,294	1,836 Added 65.83%	4,625 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $263,516 - $297,198	-1,174 Reduced 29.62%	2,789 $629,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $914,303 - $1.02 Million	3,963 New	3,963 $965,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $262,027 - $289,871	-1,195 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $237,661 - $271,982	1,195 New	1,195 $269,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $295,228 - $391,554	-1,620 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $306,520 - $393,984	1,620 New	1,620 $391,000
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $199,260 - $223,812	-1,200 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $406,632 - $475,200	-2,400 Reduced 66.67%	1,200 $205,000
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $607,644 - $678,924	3,600	3,600 $626,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.